Levamisole FDA Link

An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6)

Also Known As:

Decaris; Dekaris; Levamisole Hydrochloride; Solaskil; Hydrochloride, Levamisole; L-Tetramisole; Levotetramisole; Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, (S)-

Pharmalogical Action Categories:

Adjuvants, Immunologic
Antinematodal Agents
Antirheumatic Agents

Organic Chemicals: 133
- Sulfur Compounds: 278
  - Thiazoles: 392
    - Levamisole: 2188
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Thiazoles: 392
      - Levamisole: 2188
    - Imidazoles: 150
      - Levamisole: 2188

Cassidy B Johnson Selected Research

Cassidy B Johnson Research Topics

Disease

Drug/Important Bio-Agent (IBA)